Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 18/20 | 0.67 |
| ▸ | GSK3B | P49841 | 13/20 | 0.67 |
| ▸ | CDK1 | P06493 | 2/20 | 0.56 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.53 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.47 |
| ▸ | FLT3 | P36888 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14427515 | 0.90 | CDK2 (0.82) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL13885674 | 0.90 | CDK2 (0.66) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL13885060 | 0.85 | GSK3B (0.60) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL13309212 | 0.85 | CDK2 (0.58) | CDK2GSK3BMAPKAPK2CHEK1CCNE1 | |
| SCHEMBL13885181 | 0.85 | CDK2 (0.54) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL11931070 | 0.85 | CDK2 (0.54) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL14427488 | 0.81 | CDK2 (1.00) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL14427362 | 0.81 | CDK2 (1.00) | CDK2GSK3BCDK1MAPKAPK2CHEK1 | |
| SCHEMBL14367581 | 0.80 | CDK2 (0.84) | CDK2GSK3BCDK1CHEK1PTGS2 | |
| SCHEMBL14427533 | 0.80 | CDK2 (0.65) | CDK2GSK3BMAPKAPK2CCNE1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514442-B2 | Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2009-04-07 | — | — | US | disclosed |
| EP-1534712-B1 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORP (US) | 2007-05-16 | — | — | EP | disclosed |
| WO-2007044420-A1 | PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER | SCHERING CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
| US-7205308-B2 | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2007-04-17 | — | — | US | disclosed |
| US-7205308-B2 | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2007-04-17 | — | — | US | disclosed |